Trial results investigating the impact of Medicaid Health Home on patients with Type 2 Diabetes were posted on ClinicalTrials.gov on 2025-07-04. The study, involving 96,759 participants, found that Health Home patients experienced fewer diabetes-related preventable hospitalizations compared to non-Health Home patients.
Background
Type 2 diabetes is a widespread condition in the United States, affecting approximately 1 in 10 people. The disease can lead to severe health complications, including hospitalizations, kidney failure, blindness, amputations, heart attacks, strokes, painful nerve damage (neuropathy), and premature death. Patients with diabetes often face significant barriers to managing their risk factors, adhering to medical recommendations, and accessing necessary healthcare services to prevent these complications. This is especially true for those with co-existing health issues, those living in poverty, and racial/ethnic minorities.
Trial design
This completed study enrolled 96,759 participants to assess the impact of a Medicaid Health Home program on patients with Type 2 Diabetes Mellitus in New York City. The study compared outcomes between patients enrolled in the Health Home program and those not enrolled, focusing on healthcare utilization and engagement.
Key results
The study reported several key measurements comparing Health Home patients to Non-Health Home patients:
- Number of Enrollees With Diabetes-related Preventable Hospitalizations:
- In one measurement, Health Home Patients had 48 participants with preventable hospitalizations, compared to 109 for Non-Health Home Patients.
- In another measurement, Health Home Patients again had 48 participants with preventable hospitalizations, while Non-Health Home Patients had 90.
- Number of Primary Care Visits:
- Health Home Patients had a mean of 10.9 (Standard Deviation 10.9) visits.
- Non-Health Home Patients had a mean of 8.7 (Standard Deviation 10.9) visits.
- Number of Months of Medicaid Coverage:
- Health Home Patients had a mean of 11.7 (Standard Deviation 1.3) months.
- Non-Health Home Patients had a mean of 10.7 (Standard Deviation 1.3) months.
What this means
The findings suggest that enrollment in a Medicaid Health Home program may be associated with improved health outcomes and healthcare engagement for patients with Type 2 Diabetes. Specifically, Health Home patients demonstrated fewer diabetes-related preventable hospitalizations and a higher average number of primary care visits. The increased duration of Medicaid coverage among Health Home patients also indicates potentially better continuity of care and access to services, which are crucial for managing a chronic condition like Type 2 Diabetes and preventing severe complications.
Source
The information for these trial results was sourced from ClinicalTrials.gov, a public registry of clinical studies. The results for study NCT02713321, titled 'Impact of Medicaid Health Home on Patients With Diabetes in New York City', were posted on 2025-07-04 on clinicaltrials.gov.